Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Introduction of Dispersible 3HP Formulations for TB Preventive Treatment in Children: a Multi-country Evaluation

NCT06511180 is registered in ClinicalTrials.gov with The Aurum Institute NPC as lead sponsor.

NCT NCT06511180
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06511180 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Introduction of Dispersible 3HP Formulations for TB Preventive Treatment in Children: a Multi-country Evaluation
Lead sponsor
The Aurum Institute NPC
Phase
Observational
Overall status
Unknown status
Start date
August 31, 2024
Completion date
June 30, 2025
Enrollment
1,200 (estimated)
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

children, only, hiv, household contact, tb - tuberculosis